Jan Herden

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

MicroRNA 15a, Inversely Correlated to PKCα, Is a Potential Marker to Differentiate between Benign and Malignant Renal Tumors in Biopsy and Urine Samples

Melanie von Brandenstein, Jency J. Pandarakalam, L. de Kroon et al. · American Journal Of Pathology · 2012 · 112 citations

Urology, Tumoral Pathology, Genitourinary Cancer +13

Patient–physician communication and health‐related quality of life of patients with localised prostate cancer undergoing radical prostatectomy – a longitudinal multilevel analysis

Nicole Ernstmann, Jan Herden, Nicola Winter et al. · British Journal of Urology · 2016 · 51 citations

Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy

Friederike Kendel, Lukas Helbig, Konrad Neumann et al. · International Journal of Cancer · 2016 · 25 citations · Full text

Distinct distribution patterns of exercise-induced natural killer cell mobilization into the circulation and tumor tissue of patients with prostate cancer

Alexander Schenk, Tobias Esser, Sergen Belen et al. · American Journal of Physiology-Cell Physiology · 2022 · 21 citations · Full text

Immunology, Cell Death, Immunologic Mechanism +21